litlas
Log inCreate account

Thomas A. Luger

Active 1981–2024

Also published as
Thomas A Luger
167
Papers
32,669
Citations
110
h-index
166
i10-index

Citations

Citations per year for Thomas A. Luger1981: 1 citations1982: 8 citations1983: 13 citations1984: 16 citations1985: 11 citations1986: 22 citations1987: 20 citations1988: 27 citations1989: 30 citations1990: 72 citations1991: 55 citations1992: 78 citations1993: 72 citations1994: 66 citations1995: 82 citations1996: 115 citations1997: 87 citations1998: 148 citations1999: 147 citations2000: 181 citations2001: 196 citations2002: 185 citations2003: 195 citations2004: 191 citations2005: 228 citations2006: 250 citations2007: 237 citations2008: 198 citations2009: 239 citations2010: 227 citations2011: 259 citations2012: 187 citations2013: 229 citations2014: 217 citations2015: 210 citations2016: 220 citations2017: 271 citations2018: 262 citations2019: 885 citations2020: 783 citations2021: 708 citations2022: 507 citations2023: 389 citations2024: 565 citations2025: 248 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,884 citing papers, 23.3% of this breakdownGermany: 1,296 citing papers, 10.4% of this breakdownUnited Kingdom: 878 citing papers, 7.1% of this breakdownChina: 639 citing papers, 5.2% of this breakdownItaly: 567 citing papers, 4.6% of this breakdownFrance: 550 citing papers, 4.4% of this breakdownJapan: 495 citing papers, 4% of this breakdownCanada: 465 citing papers, 3.7% of this breakdownSwitzerland: 356 citing papers, 2.9% of this breakdownNetherlands: 350 citing papers, 2.8% of this breakdownSpain: 306 citing papers, 2.5% of this breakdownAustralia: 279 citing papers, 2.2% of this breakdown
0%23.3%Other 26.9%

Institutions

Fields

  • Medicine56.1%
  • Immunology and Microbiology18.3%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Neuroscience4.7%
  • Materials Science2.2%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • Other4.6%

Topics

  • Dermatology and Skin Diseases10%
  • Psoriasis: Treatment and Pathogenesis5.9%
  • Allergic Rhinitis and Sensitization3.3%
  • Spondyloarthritis Studies and Treatments3.1%
  • Asthma and respiratory diseases2.8%
  • Skin Protection and Aging2.6%
  • Other72.3%

Coauthors

All papers

Open in search
  1. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

    Authors: Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki, Kristian Reich, David A. Amato, Susan Ball, Daniel Braun, Gregory S. Cameron, J. Erickson, Robert J. Konrad, Talia M. Muram, Brian J. Nickoloff, Olawale Osuntokun, Roberta J. Secrest, Fangyi Zhao, Lotus Mallbris, Craig L. Leonardi - New England Journal of Medicine 2016 cited by 838

  2. The microbiome in patients with atopic dermatitis

    Authors: Amy S. Paller, Heidi H. Kong, Patrick C. Seed, Shruti Naik, Tiffany C. Scharschmidt, Richard L. Gallo, Thomas A. Luger, Alan D. Irvine - Journal of Allergy and Clinical Immunology 2018 cited by 531

  3. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents

    Authors: Thomas A. Luger, Masayuki Amagai, Brigitte Dréno, Marie-Ange Dagnelie, Wilson Liao, Kenji Kabashima, Tamara Schikowski, Ehrhardt Proksch, Peter M. Elias, Michel Simon, Eric L. Simpson, Erin E. Grinich, Matthias Schmuth - Journal of Dermatological Science 2021 cited by 195

  4. Nanomedicine—Challenge and Perspectives

    Authors: Kristina Riehemann, Stefan W. Schneider, Thomas A. Luger, Biana Godin, Mauro Ferrari, Harald Fuchs - Angewandte Chemie International Edition 2009 cited by 1,290

  5. Evidence and impact of neutrophil extracellular traps in malignant melanoma

    Authors: Fiona Schedel, Sarah Mayer‐Hain, Karin Pappelbaum, Dieter Metze, Martin Stock, Tobias Goerge, Karin Loser, Cord Sunderkötter, Thomas A. Luger, Carsten Weishaupt - Pigment Cell & Melanoma Research 2019 cited by 127

  6. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

    Authors: Kim Papp, Alan Menter, Mai Abe, Boni E. Elewski, Steven R. Feldman, Alice B. Gottlieb, Richard G. Langley, Thomas A. Luger, Diamant Thaçi, M. Buonanno, Pankaj Gupta, James Proulx, Shu-Ping Lan, Robert Wołk, the OPT Pivotal 1 and OPT Pivotal 2 investigators - British Journal of Dermatology 2015 cited by 322

  7. Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder

    Authors: Patrick M. Brunner, Jonathan I. Silverberg, Emma Guttman‐Yassky, Amy S. Paller, Kenji Kabashima, Masayuki Amagai, Thomas A. Luger, Mette Deleuran, Thomas Werfel, Kilian Eyerich, Georg Stingl, M. Bagot, DirkJan Hijnen, Michael R. Ardern‐Jones, Nick J. Reynolds, Phyllis I. Spuls, Alain Taı̈eb - Journal of Investigative Dermatology 2016 cited by 377

  8. Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress

    Authors: Andrzej Słomiński, Jacobo Wortsman, Thomas A. Luger, Ralf Paus, Samuel Solomon - Physiological Reviews 2000 cited by 771

  9. Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin

    Authors: Martin Steinhoff, Ulrich Neisius, Akihiko Ikoma, Manigé Fartasch, G. Heyer, Per S. Skov, Thomas A. Luger, Martin Schmelz - Journal of Neuroscience 2003 cited by 642

  10. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    Authors: Laure Gossec, Maarten de Wit, Uta Kiltz, Jürgen Braun, Umut Kalyoncu, Rossana Scrivo, Mara Maccarone, Laurence Carton, Kati Otsa, Imre Sooäär, Turid Heiberg, Heidi Bertheussen, Juan D. Cañete, Anselm Sánchez Lombarte, Andra Bălănescu, Alina Dinte, Kurt de Vlam, Josef S Smolen, Tanja Stamm, Dora Niedermayer, Gábor Békés, Douglas J. Veale, Philip Helliwell, Andrew Parkinson, Thomas A. Luger, Tore K. Kvien - Annals of the Rheumatic Diseases 2014 cited by 421

  11. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II

    Authors: Johannes Ring, A. Alomar, Thomas Bieber, Mette Deleuran, A. Fink‐Wagner, C. Gelmetti, Uwe Gieler, Jasna Lipozenčić, Thomas A. Luger, A. P. Oranje, T. Schäfer, Thomas Schwennesen, Stefania Seidenari, Dagmar Simon, Sonja Ständer, Georg Stingl, S. Szalai, Jacek C. Szepietowski, Alain Taı̈eb, Thomas Werfel, Andreas Wollenberg, Ulf Darsow - Journal of the European Academy of Dermatology and Venereology 2012 cited by 361

  12. A Synthetic Sandalwood Odorant Induces Wound-Healing Processes in Human Keratinocytes via the Olfactory Receptor OR2AT4

    Authors: Daniela Busse, Philipp Kudella, Nana‐Maria Grüning, Günter Gisselmann, Sonja Ständer, Thomas A. Luger, Frank Jacobsen, L. Steinsträßer, Ralf Paus, Paraskevi Gkogkolou, Markus Böhm, Hanns Hatt, Heike Benecke - Journal of Investigative Dermatology 2014 cited by 233

  13. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures

    Authors: Sonja Ständer, Corinna Moormann, Mark Schumacher, Joerg Buddenkotte, Metin Artuc, Victoria Shpacovitch, Thomas Brzoska, Undine Lippert, Beate M. Henz, Thomas A. Luger, Dieter Metze, Martin Steinhoff - Experimental Dermatology 2004 cited by 404

  14. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

    Authors: Laure Gossec, Josef S Smolen, Sofía Ramiro, M. De Wit, Maurizio Cutolo, Maxime Dougados, Paul Emery, R. Landewé, Susan Oliver, Daniel Aletaha, Neil Betteridge, Jürgen Braun, Gerd R Burmester, Juan D. Cañete, Nemanja Damjanov, Oliver FitzGerald, Emma Haglund, Philip Helliwell, T. K. Kvien, Rik Lories, Thomas A. Luger, Mara Maccarone, Helena Marzo‐Ortega, Dennis McGonagle, Iain B. McInnes, Ignazio Olivieri, Karel Pavelká, Georg Schett, Joachim Sieper, Filip Van den Bosch, Douglas J. Veale, J. Wollenhaupt, A. Zink, Désirée van der Heijde - Annals of the Rheumatic Diseases 2016 cited by 913

  15. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I

    Authors: Johannes Ring, A. Alomar, Thomas Bieber, Mette Deleuran, A. Fink‐Wagner, C. Gelmetti, Uwe Gieler, Jasna Lipozenčić, Thomas A. Luger, A. P. Oranje, T. Schäfer, Thomas Schwennesen, Stefania Seidenari, Dagmar Simon, Sonja Ständer, Georg Stingl, S. Szalai, Jacek C. Szepietowski, Alain Taı̈eb, Thomas Werfel, Andreas Wollenberg, Ulf Darsow - Journal of the European Academy of Dermatology and Venereology 2012 cited by 682

  16. Clinical, Cellular, and Molecular Aspects in the Pathophysiology of Rosacea

    Authors: Martin Steinhoff, Joerg Buddenkotte, Jérôme Aubert, Mathias Sulk, Pawel Novak, Verena D. Schwab, Christian Meß, Ferda Cevikbas, Michel Rivier, Isabelle Carlavan, Sophie Déret, Carine Rosignoli, Dieter Metze, Thomas A. Luger, Johannes J. Voegel - Journal of Investigative Dermatology Symposium Proceedings 2011 cited by 278

  17. The Role of a Novel Generation of Emollients, ‘Emollients Plus’, in Atopic Dermatitis

    Authors: Elena Araviiskaia, Carlo Pincelli, Adele Sparavigna, Thomas A. Luger - Clinical Cosmetic and Investigational Dermatology 2022 cited by 47

  18. α-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effects in Vitro and in Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases

    Authors: Thomas Brzoska, Thomas A. Luger, Christian Maaser, Christoph Abels, Markus Böhm - Endocrine Reviews 2008 cited by 320

  19. The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells

    Authors: Karin Loser, Thomas Vogl, Maik Voskort, Aloys Lueken, Verena Kupas, Wolfgang Nacken, Lars Klenner, Annegret Kuhn, Dirk Foell, Lydia Sorokin, Thomas A. Luger, Johannes Roth, Stefan Beissert - Nature Medicine 2010 cited by 294

  20. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

    Authors: Hywel C Williams, Fenella Wojnarowska, Gudula Kirtschig, James Mason, Thomas Godec, Enno Schmidt, Joanne R Chalmers, Margaret Childs, Shernaz Walton, Karen Harman, Anna Chapman, Diane Whitham, Andrew Nunn, Jerry M. Adams, Victoria Akhras, A. Anstey, C.N. Barnard, Hazel Κ. Bell, S. Blackford, E.‐B. Bröcker, A.J. Carmichael, Rúben Coelho, Fiona E. Craig, Kathy J Davies, R Ellis, J.S.C. English, Regine Gläser, Richard Groves, C Günthert, Philip Hampton, N. C. Hepburn, Rainer Hügel, K Hussain, Jackie Ingram, Alison Layton, N. J. Levell, Victor L. Lewis, H Malhomme, A Omerod, Girish K. Patel, Ruth Rallan, Jane Ravenscroft, Henk Santander, Kerstin Steinbrink, Michael Sticherling, C. Abasq Thomas, M Vatve, Nina van Beek, Vanessa Venning, Emma Veysey, Rachel Wachsmuth, Shyamal Wahie, Benjamin Walker, Michael Walsh, J. S. Wee, Michael Westmoreland, G Wong, Adam Ferguson, Indre Verpetinske, Emilia Duarte-Williamson, Fiona Antony, Chris Bower, David J. Gawkrodger, Kathy Taghipour, M. G. S. Dunnill, Alex Waters, W.W. Bottomley, Andrew Wright, Jane Sterling, Adzura Azam, Sam Gibbs, Thomas A. Luger, Ingrid Salvary, Chris Lovell, A. Ilchyshyn, Karen Gibbon, Marinella Nik, R. Charles‐Holmes, Anita Lavery - The Lancet 2017 cited by 216

  21. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

    Authors: A Köck, Thomas Schwarz, Reinhard Kirnbauer, A Urbanski, P Perry, John C. Ansel, Thomas A. Luger - The Journal of Experimental Medicine 1990 cited by 709

  22. Consensus conference on pediatric atopic dermatitis

    Authors: Lawrence F. Eichenfield, Jon M. Hanifin, Thomas A. Luger, Seth R. Stevens, Howard B. Pride - Journal of the American Academy of Dermatology 2003 cited by 291

  23. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus‐Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis

    Authors: Laura C. Coates, Oliver FitzGerald, Joseph F. Merola, Josef S Smolen, Leonieke van Mens, Heidi Bertheussen, Wolf‐­Henning Boehncke, Kristina Callis Duffin, Willemina Campbell, Maarten de Wit, Dafna D. Gladman, Alice B. Gottlieb, Jana James, Arthur Kavanaugh, Lars Erik Kristensen, Tore K. Kvien, Thomas A. Luger, Neil McHugh, Philip Mease, Peter Nash, Alexis Ogdie, Cheryl F. Rosen, Vibeke Strand, William Tillett, Douglas J. Veale, Philip Helliwell - Arthritis & Rheumatology 2017 cited by 92

  24. The Economic and Psychosocial Comorbidity Burden Among Adults with Moderate-to-Severe Atopic Dermatitis in Europe: Analysis of a Cross-Sectional Survey

    Authors: Giampiero Girolomoni, Thomas A. Luger, Audrey Nosbaum, David Gruben, William Romero, Lyndon Llamado, Marco DiBonaventura - Dermatology and Therapy 2020 cited by 77